OS Therapies Inc
corporate_fare Company Profile
OS Therapies Inc (NYSE:OSTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for OSTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 9/10. Recent SEC coverage for OSTX spans 10-Q.
Recent high-impact activity:
- OS Therapies Q3 10-Q: Going Concern on $431,816 Cash, $30.3M Nine-Month Loss
Financial Snapshot
Short Interest & Short Volume
7.73 days to coverFINRA reported short interest of 2,760,127 shares in OSTX as of the October 30, 2026 settlement, a 2.1% decrease from the prior period — about 7.7 days to cover at its recent average daily volume. On November 20, 2026, 62.1% of OSTX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.